Abu Dhabi Partners With Biocom California to Launch Life Sciences Trade Corridor

Abu Dhabi has established a strategic life sciences corridor with California through a formal partnership with Biocom California, the largest life sciences trade association in the United States. The agreement, led by the Department of Health – Abu Dhabi (DoH), connects the emirate’s healthcare infrastructure with a network of more than 1,700 biotechnology, pharmaceutical, and medical device companies. The partnership aims to facilitate the exchange of medical research, technological innovation, and investment between the two regions. By linking Abu Dhabi’s healthcare ecosystem with California’s established biotech clusters, the initiative focuses on accelerating the development of advanced therapeutics, genomic medicine, and health-tech solutions. Clinical Research and Market Access Under the terms of the agreement, member companies of Biocom California will gain streamlined access to Abu Dhabi’s clinical trial facilities and regulatory framework. This allows US-based firms to utilize the UAE capital as a hub for Middle Eastern clinical studies, leveraging the city’s diverse population for genomic research. Conversely, Abu Dhabi-based entities will receive professional support…